108 related articles for article (PubMed ID: 28570330)
1. Neurologic Complications of Transplantation.
Pruitt AA
Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):802-821. PubMed ID: 28570330
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome and graft-versus-host disease after liver transplantation: a case report and review of the literature.
Zhu LQ; Liao SS; Jiang WT; Liu YH
Int J Clin Pharmacol Ther; 2015 Sep; 53(9):783-7. PubMed ID: 26227100
[TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome in the Intensive Care Unit after liver transplant: a comparison of our experience with the existing literature.
Lunardi N; Saraceni E; Boccagni P; Segato M; Bortolato A; Manara R; Rossi S; Ori C
Minerva Anestesiol; 2012 Jul; 78(7):847-50. PubMed ID: 21701444
[TBL] [Abstract][Full Text] [Related]
4. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.
Gaziev J; Marziali S; Paciaroni K; Isgrò A; Di Giuliano F; Rossi G; Marziali M; De Angelis G; Alfieri C; Ribersani M; Andreani M; Palmieri MG; Placidi F; Romigi A; Izzi F; Floris R; Mercuri NB
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1531-1540. PubMed ID: 28602890
[TBL] [Abstract][Full Text] [Related]
5. PRES in Children Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation.
Masetti R; Cordelli DM; Zama D; Vendemini F; Biagi C; Franzoni E; Pession A
Pediatrics; 2015 May; 135(5):890-901. PubMed ID: 25917987
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
7. Early-onset posterior reversible encephalopathy syndrome after solid organ transplantation in pediatric patients: a report of 2 cases.
Araz C; Camkiran A; Zeyneloglu P; Sezgin A; Moray G; Pirat A; Arslan G
Transplant Proc; 2013; 45(10):3555-7. PubMed ID: 24314957
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitor-free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation.
Shkalim-Zemer V; Konen O; Levinsky Y; Michaeli O; Yahel A; Krauss A; Yaniv I; Stein J
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417553
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome after liver transplantation in children: a rare complication related to calcineurin inhibitor effects.
Santos MM; Tannuri AC; Gibelli NE; Ayoub AA; Maksoud-Filho JG; Andrade WC; Velhote MC; Silva MM; Pinho ML; Miyatani HT; Susuki L; Tannuri U
Pediatr Transplant; 2011 Mar; 15(2):157-60. PubMed ID: 21155957
[TBL] [Abstract][Full Text] [Related]
10. Posterior reversible encephalopathy syndrome after kidney transplantation in pediatric recipients: Two cases.
Giussani A; Ardissino G; Belingheri M; Dilena R; Raiteri M; Pasciucco A; Colico C; Beretta C
Pediatr Transplant; 2016 Feb; 20(1):68-71. PubMed ID: 26607205
[TBL] [Abstract][Full Text] [Related]
11. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Rubio MT; Labopin M; Blaise D; Socié G; Contreras RR; Chevallier P; Sanz MA; Vigouroux S; Huynh A; Shimoni A; Bulabois CE; Caminos N; López-Corral L; Nagler A; Mohty M
Haematologica; 2015 May; 100(5):683-9. PubMed ID: 25769546
[TBL] [Abstract][Full Text] [Related]
12. Reversible posterior leukoencephalopathy syndrome: diagnosis and management in the setting of lung transplantation.
Tsang BK; Kermeen FD; Hopkins PM; Chambers DC
Intern Med J; 2010 Oct; 40(10):716-20. PubMed ID: 21038537
[TBL] [Abstract][Full Text] [Related]
13. Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.
Chen S; Hu J; Xu L; Brandon D; Yu J; Zhang J
Mol Neurobiol; 2016 Dec; 53(10):6897-6909. PubMed ID: 26666662
[TBL] [Abstract][Full Text] [Related]
14. Renal Disease and Neurology.
Hocker SE
Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):722-743. PubMed ID: 28570326
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
16. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
17. Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.
Savani BN; Labopin M; Kröger N; Finke J; Ehninger G; Niederwieser D; Schwerdtfeger R; Bunjes D; Glass B; Socié G; Ljungman P; Craddock C; Baron F; Ciceri F; Gorin NC; Esteve J; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Jun; 101(6):773-80. PubMed ID: 26969081
[TBL] [Abstract][Full Text] [Related]
18. Severe hypercholesterolemia in patients with graft-vs-host disease affecting the liver after stem cell transplantation.
Joukhadar R; Chiu K
Endocr Pract; 2012; 18(1):90-7. PubMed ID: 21940276
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DD
Am J Hematol; 2015 May; 90(5):392-9. PubMed ID: 25615933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
